Peer-influenced content. Sources you trust. No registration required. This is HCN.
ReachMD
The landscape of small cell lung cancer treatment is undergoing significant transformation with the advent of immune checkpoint inhibitors. This shift not only provides new therapeutic options but emphasizes the importance of a comprehensive team approach, including early detection strategies, and holds the promise for enhanced patient prognosis.
Oncology, Medical August 1st 2023
Medical Professionals Reference (MPR)
Cipla’s recall of six batches of Albuterol Sulfate Inhalation Aerosol due to a container defect necessitates immediate attention for patient safety. Replacement inhalers must be obtained by consumers from these specific batches to prevent any potential adverse effects.
Allergy & Immunology July 31st 2023
The New England Journal of Medicine
Uncover the potential of dupilumab in managing COPD patients with type 2 inflammation as this Phase 3 trial reveals fewer exacerbations, improved lung function, and enhanced life quality among the treated cohort.
Allergy & Immunology July 27th 2023
The FDA’s approval of Beyfortus offers a promising tool for RSV disease prevention in neonates and young children. This novel intervention, underscored by robust clinical trial data, marks a crucial stride towards protecting infant health in the US.
Pediatrics July 27th 2023
ACP Hospitalist
The new recommendations include continuing antiplatelet therapy for patients with a baseline indication for it, starting dual antiplatelet therapy for patients with confirmed ACS, and adding prophylactic-dose LMWH for patients on antiplatelet therapy for a previous stroke.
Cardiology July 12th 2023
American Thoracic Society
Examine the case of a young smoker with acute dyspnea whose chest CT reveals oddly shaped cysts to uncover a mystery that goes beyond usual diagnostics and leads us into the world of uncommon lung disorders.
Pulmonology June 22nd 2023